Pouiré Yaméogo (Pouiré Yameogo)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 9

Top Topics

Protein Protein

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Pouiré Yaméogo, Catherine Gérard, Nathalie Majeau, Jacques P Tremblay
Removal of the GAA repeat in the heart of a Friedreich's ataxia mouse model using CjCas9. Gene therapy (2023)
Pouiré Yaméogo, Nathalie Majeau, Cedric Happi Mbakam, Jacques P Tremblay
Small-molecule inhibitors of proteasome increase CjCas9 protein stability. PloS one 18 (1) (2023)
Pouiré Yaméogo, Nathalie Majeau, Cedric Happi Mbakam, Jacques P Tremblay
Small-molecule inhibitors of proteasome increase CjCas9 protein stability. PloS one 18 (1) (2023)
Camille Bouchard, Catherine Gérard, Solange Gni-Fiene Yanyabé, Nathalie Majeau, Malek Aloui, Gabrielle Buisson, Pouiré Yaméogo, Vanessa Couture, Jacques P Tremblay
Finding an Appropriate Mouse Model to Study the Impact of a Treatment for Friedreich Ataxia on the Behavioral Phenotype. Genes 14 (8) (2023)
Pouiré Yaméogo, Nathalie Majeau, Cedric Happi Mbakam, Jacques P Tremblay
Small-molecule inhibitors of proteasome increase CjCas9 protein stability. PloS one 18 (1) (2023)
Pouiré Yaméogo, Nathalie Majeau, Cedric Happi Mbakam, Jacques P Tremblay
Small-molecule inhibitors of proteasome increase CjCas9 protein stability. PloS one 18 (1) (2023)
Pouiré Yaméogo, Nathalie Majeau, Cedric Happi Mbakam, Jacques P Tremblay
Small-molecule inhibitors of proteasome increase CjCas9 protein stability. PloS one 18 (1) (2023)
Cedric Happi Mbakam, Joël Rousseau, Guillaume Tremblay, Pouiré Yaméogo, Jacques P Tremblay
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular Dystrophy. International journal of molecular sciences 23 (11) (2022)
Pouiré Yaméogo, Benjamin L Duchêne, Nathalie Majeau, Jacques P Tremblay
CRISPR-SCReT (CRISPR-Stop Codon Read Through) method to control Cas9 expression for gene editing. Gene therapy (2021)